Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Biohaven Ltd., 3 years.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Veradermics Incorporated | Open-market sale | −15,000 | $106.14 | $1,592,100 |
| Aug 12, 2026 | Veradermics Incorporated | Open-market sale | −80,000 | $107.23 | $8,578,400 |
| Aug 12, 2026 | Veradermics Incorporated | Open-market sale | −5,000 | $108.24 | $541,200 |
| Feb 5, 2026 | Veradermics Incorporated | Derivative conversion | +480,269 | — | — |
| Feb 5, 2026 | Veradermics Incorporated | Derivative conversion | +906,862 | — | — |
| Feb 5, 2026 | Veradermics Incorporated | Derivative conversion | +520,758 | — | — |
| Feb 5, 2026 | Veradermics Incorporated | Open-market purchase | +294,117 | $17.00 | $4,999,989 |
| Nov 13, 2025 | Biohaven Ltd. | Open-market purchase | +3,333,333 | $7.50 | $24,999,998 |
| Mar 4, 2025 | Biohaven Ltd. | Open-market purchase | +25,000 | $30.39 | $759,750 |
| Mar 4, 2025 | Biohaven Ltd. | Open-market purchase | +3,400 | $30.73 | $104,482 |
| Mar 4, 2025 | Biohaven Ltd. | Open-market purchase | +3,400 | $30.73 | $104,482 |
| Mar 4, 2025 | Biohaven Ltd. | Open-market purchase | +900 | $30.73 | $27,657 |
| Dec 30, 2024 | Biohaven Ltd. | Open-market purchase | +29,000 | $35.94 | $1,042,260 |
| Oct 2, 2024 | Biohaven Ltd. | Open-market purchase | +21,052 | $47.50 | $999,970 |
| Jul 18, 2024 | Biohaven Ltd. | Open-market purchase | +28,400 | $35.67 | $1,013,028 |
Questions about John W. Childs
What boards is John W. Childs on?
John W. Childs sits on the boards of Biohaven Ltd. and Veradermics Incorporated.
How long has John W. Childs served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.